BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berry-bibee EN, Kim M, Simmons KB, Tepper NK, Riley HE, Pagano HP, Curtis KM. Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review. Contraception 2016;94:650-67. [DOI: 10.1016/j.contraception.2016.07.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Pellikaan K, Ben Brahim Y, Rosenberg AGW, Davidse K, Poitou C, Coupaye M, Goldstone AP, Høybye C, Markovic TP, Grugni G, Crinò A, Caixàs A, Eldar-Geva T, Hirsch HJ, Gross-Tsur V, Butler MG, Miller JL, van der Kuy PM, van den Berg SAA, Visser JA, van der Lely AJ, de Graaff LCG. Hypogonadism in Women with Prader-Willi Syndrome-Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion. J Clin Med 2021;10:5781. [PMID: 34945077 DOI: 10.3390/jcm10245781] [Reference Citation Analysis]
2 Curtis KM, Tepper NK, Jatlaoui TC, Whiteman MK. Removing medical barriers to contraception — evidence-based recommendations from the Centers for Disease Control and Prevention, 2016. Contraception 2016;94:579-81. [DOI: 10.1016/j.contraception.2016.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Robakis T, Williams KE, Nutkiewicz L, Rasgon NL. Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research. Curr Psychiatry Rep 2019;21:57. [PMID: 31172309 DOI: 10.1007/s11920-019-1034-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
4 Rapkin AJ, Korotkaya Y, Taylor KC. Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives. Open Access J Contracept 2019;10:27-39. [PMID: 31572029 DOI: 10.2147/OAJC.S183193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bourne C, Kenkel L. Treatment of Depression in Women. Handb Exp Pharmacol 2019;250:371-87. [PMID: 30341726 DOI: 10.1007/164_2018_163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Pagano HP, Zapata LB, Berry-bibee EN, Nanda K, Curtis KM. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Contraception 2016;94:641-9. [DOI: 10.1016/j.contraception.2016.06.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
7 Simmons K, Haddad L, Nanda K, Curtis K. Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review. BJOG: Int J Obstet Gy 2018;125:804-11. [DOI: 10.1111/1471-0528.15027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
8 Ti A, Stone RH, Whiteman M, Curtis KM. Safety and effectiveness of hormonal contraception for women who use opioids: A systematic review. Contraception 2019;100:480-3. [DOI: 10.1016/j.contraception.2019.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 . ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. Obstet Gynecol 2019;133:e128-50. [PMID: 30681544 DOI: 10.1097/AOG.0000000000003072] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 10.7] [Reference Citation Analysis]
10 Raeder F, Heidemann F, Schedlowski M, Margraf J, Zlomuzica A. No pills, more skills: The adverse effect of hormonal contraceptive use on exposure therapy benefit. Journal of Psychiatric Research 2019;119:95-101. [DOI: 10.1016/j.jpsychires.2019.09.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
11 Brand BA, Haveman YRA, de Beer F, de Boer JN, Dazzan P, Sommer IEC. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol Med 2021;:1-15. [PMID: 34763737 DOI: 10.1017/S0033291721004591] [Reference Citation Analysis]
12 Young Holt B, Dellplain L, Creinin MD, Peine KJ, Romano J, Hemmerling A. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV. Eur J Contracept Reprod Health Care 2018;23:326-34. [PMID: 30247084 DOI: 10.1080/13625187.2018.1508650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Horton LG, Folger SG, Berry-bibee E, Jatlaoui TC, Tepper NK, Curtis KM. Research gaps from evidence-based contraception guidance: the US Medical Eligibility Criteria for Contraceptive Use, 2016, and the US Selected Practice Recommendations for Contraceptive Use, 2016. Contraception 2016;94:582-9. [DOI: 10.1016/j.contraception.2016.07.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
14 Simmons KB, Haddad LB, Nanda K, Curtis KM. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. American Journal of Obstetrics and Gynecology 2018;218:88-97.e14. [DOI: 10.1016/j.ajog.2017.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]